Valneva SE (AYJ)
XETR
Real-time Data
07:00 AM
Day's Range
2.8052 wk Range
2.04Overview - AYJ - Valneva SE
Key Statistics
Valuation
Enterprise Value
650.05M
P/E (Trailing)
‪70.97‬
PEG Ratio
‪0.35‬
Price / Sales (TTM)
‪3.79‬
Price / Book
‪6.69‬
EV / EBITDA
‪-6.58‬
Profitability
Gross Margin
‪15.28%‬
Profit Margin
‪-110.29%‬
Operating Margin
‪-74.91%‬
Return on Assets
‪-16.68%‬
Return on Equity
‪-117.84%‬
Ownership
Shares Outstanding
173.75M
Float
157.26M
Held by Insiders
‪10.72%‬
Held by Institutions
‪24.41%‬
Price stats
Beta
‪1.34‬
50-Day Avg
‪2.34‬
200-Day Avg
‪3.21‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - AYJ - Valneva SE
Peers - AYJ - Valneva SE
Peer Comparison
Compared with companies in Biotechnology listed on XETR.
- AYJXETRValneva SE561.35MMarket Cap-33.31%52-week change70.98P/E (Trailing)‪-110.29%‬Profit Margin
- ANLXETRAnalog Devices, Inc.156.54BMarket Cap+32.98%52-week change44.45P/E (Trailing)‪29.78%‬Profit Margin
- 0QFXETRModerna, Inc.51.94BMarket Cap+82.12%52-week change-17.03P/E (Trailing)‪-141.42%‬Profit Margin
- 22UAXETRBioNTech SE25.54BMarket Cap+7.30%52-week change157.87P/E (Trailing)‪-63.63%‬Profit Margin
- BBZAXETRBB Biotech AG3.28BMarket Cap-4.04%52-week change13.32P/E (Trailing)‪127.31%‬Profit Margin
- BV3XETRBavarian Nordic A/S1.81BMarket Cap+6.58%52-week change11.74P/E (Trailing)‪19.70%‬Profit Margin
- BSTXETRBastei Lübbe AG85.93MMarket Cap-57.01%52-week change13.50P/E (Trailing)‪5.36%‬Profit Margin
Profile Summary - AYJ - Valneva SE
About
Valneva SE is a specialty vaccine company headquartered in Saint-Herblain, France, that develops, manufactures, and commercializes prophylactic vaccines targeting infectious diseases with significant unmet medical needs. Its commercial portfolio features three key vaccines: IXIARO®, for Japanese encephalitis;…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
